Mounjaro lawsuits allege that some users developed gastroparesis, stomach paralysis, intestinal obstruction, severe vomiting, dehydration, malnutrition, kidney injury related to fluid loss, and other digestive complications after using the drug
Patients with well-managed hypothyroidism on stable levothyroxine replacement can generally proceed with GLP-1 therapy if clinically indicated
In another unique multicenter cohort, which included 20 patients with biopsy-confirmed NASH and F2-F3 fibrosis, after treatment with pegozafermin at a dose of 27 mg weekly for 20 weeks, an improvement 2 points in the NAFLD activity score (NAS) with 1 point in ballooning or lobular inflammation, and without worsening of fibrosis, was observed in 63% of patients, with a marked reduction in hepatic fat by MRI-PDFF (64.7%
refrigerate for optimal quality
Note that the costs, dosages, and approved uses are U.S.-based
3 GLP-1R mediated signaling enhances DVC neuron synaptic inputs
